Vince
Lamanna,
President
(Organization)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-08-08
Posted date:
2024-09-16
Communication number:
360616-612250
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Matthew Trnkus,
Policy Advisor
| Office of the Minister of Foreign Affairs
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health,
International Trade
Communication date:
2024-07-22
Posted date:
2024-08-15
Communication number:
360616-611661
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Andrew Cardozo,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-07-17
Posted date:
2024-08-15
Communication number:
360616-611497
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Chelios Vuong,
Policy Advisor
| Office of the Minister of Foreign Affairs
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health,
International Trade
Communication date:
2024-07-15
Posted date:
2024-08-15
Communication number:
360616-611033
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jeremy Bruce,
Deputy Director, Policy
| Office of the Minister of Foreign Affairs
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health,
International Trade
Communication date:
2024-07-09
Posted date:
2024-08-15
Communication number:
360616-609919
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Judith Seidman,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-06-05
Posted date:
2024-07-15
Communication number:
360616-607097
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Earl Dreeshen,
Member of Parliament
| Red Deer—Mountain View
|
House of Commons
-
Blaine Calkins,
Member of Parliament
| Red Deer—Lacombe
|
House of Commons
-
Tom Kmiec,
Member of Parliament
| Calgary Shepard
|
House of Commons
-
Stephen Ellis,
Member of Parliament, Cumberland-Colchester
|
House of Commons
Subject Matter of the communication:
Health,
Research and Development,
Science and Technology
Communication date:
2024-05-23
Posted date:
2024-06-15
Communication number:
360616-607098
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sharon Burey,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-03-27
Posted date:
2024-04-15
Communication number:
360616-598604
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Randy Hoback,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
International Trade
Communication date:
2024-03-19
Posted date:
2024-04-15
Communication number:
360616-598440
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jade Mallette,
Director of Parliamentary Affairs
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-03-13
Posted date:
2024-04-15
Communication number:
360616-597114
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Shuvaloy Majumdar,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2024-02-28
Posted date:
2024-03-15
Communication number:
360616-595016
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-12-08
Posted date:
2024-01-15
Communication number:
360616-586544
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Connor MacDonald,
Policy Advisor
|
House of Commons
-
Jwane Izzetpanah,
Manager of Stakeholder Relations
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2023-11-15
Posted date:
2023-12-15
Communication number:
360616-585155
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Office of Life Science and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Rodrigo Arancibia,
Director
| Office of Life Science and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2023-11-14
Posted date:
2023-12-15
Communication number:
360616-584604
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Marie-Pier Fontaine,
Senior Policy Advisor
| Deputy Minister's Office
|
Health Canada (HC)
-
Celia Lourenco,
Acting Associate Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
-
Stephen Lucas,
Deputy Minister
|
Health Canada (HC)
-
Nancy Hamzawi,
Executive Vice President
|
Public Health Agency of Canada (PHAC)
-
Michael Collins,
Vice-President
| Health Promotion and Chronic Disease Prevention Branch
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2023-11-14
Posted date:
2023-12-15
Communication number:
360616-583374
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Chris Zhou,
Senior Policy and Atlantic Advisor
|
Innovation, Science and Economic Development Canada (ISED)
-
Rechie Valdez,
Minister of Small Business
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2023-11-07
Posted date:
2023-12-15
Communication number:
360616-585168
(amended from
360616-585153)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jennifer Miller,
Assistant Secretary
|
Privy Council Office (PCO)
-
Jeff Waring,
Associate Assistant Secretary
|
Privy Council Office (PCO)
Subject Matter of the communication:
Health
Communication date:
2023-11-07
Posted date:
2023-12-15
Communication number:
360616-585151
(amended from
360616-585150)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-11-07
Posted date:
2023-12-15
Communication number:
360616-584071
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Luc Theriault,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2023-11-07
Posted date:
2023-11-15
Communication number:
360616-584068
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Josh Dadjo,
Director of Parliamentary Affairs
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2023-11-06
Posted date:
2023-12-15
Communication number:
360616-585162
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Ben Chin,
Senior Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2023-11-06
Posted date:
2023-12-15
Communication number:
360616-584064
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Suzy McDonald,
Associate Deputy Minister
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2023-11-06
Posted date:
2023-12-15
Communication number:
360616-584059
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
-
Chelsea Madryga,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-10-13
Posted date:
2023-11-15
Communication number:
360616-579538
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Danna Campbell,
Director, Partnerships & Strategies
| Health Promotion and Chronic Disease Prevention Branch
|
Health Canada (HC)
-
David Luchuk,
A/Director
| Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division
|
Public Health Agency of Canada (PHAC)
-
Michael Collins,
A/Vice-President
| Health Promotion and Chronic Disease Prevention Branch
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2023-09-19
Posted date:
2023-10-16
Communication number:
360616-577177
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Stephen Ellis,
Member of Parliament, Cumberland-Colchester
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2023-05-29
Posted date:
2023-06-15
Communication number:
360616-566944
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Benoit Leduc,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Darryl Patterson,
Director General
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health
Communication date:
2023-05-04
Posted date:
2023-06-15
Communication number:
360616-564219
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Stephen Lucas,
Deputy Minister
|
Health Canada (HC)
-
Eric Belair,
Associate Assistant Deputy Minister
| Strategic Policy Branch
|
Health Canada (HC)
-
Michael Collins,
A/ Associate Deputy Minister
| Health Promotion and Chronic Disease Prevention Branch
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2023-05-03
Posted date:
2023-06-15
Communication number:
360616-564217
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jamie Kippen,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
-
Sandenga Yeba,
Deputy Director of Policy
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-04-12
Posted date:
2023-05-15
Communication number:
360616-561897
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Caroline Menard,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Razan Shahin,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2023-03-29
Posted date:
2023-04-15
Communication number:
360616-560744
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Andy Fillmore,
Parliamentary Secretary to the Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
-
Sarah MacDonald,
Special Assistant (Assistant to the Parliamentary Secretary and Parliamentary Affairs)
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2023-03-27
Posted date:
2023-04-15
Communication number:
360616-560640
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Chelsea Madryga,
Parliamentary Secretary Assistant
|
Health Canada (HC)
-
Adam van Koeverden ,
Parliamentary Secretary
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-03-21
Posted date:
2023-04-15
Communication number:
360616-560456
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Bianca Hossain,
Policy Advisor
| Office of the Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health
Communication date:
2023-03-06
Posted date:
2023-04-15
Communication number:
360616-557753
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Caroline Menard,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health
Communication date:
2023-02-16
Posted date:
2023-03-15
Communication number:
360616-557037
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Patrick Verreault,
Deputy Director
| Food Policy Division
|
Agriculture and Agri-Food Canada (AAFC)
-
Jason Baillargeon,
Director
| Food Policy Division
|
Agriculture and Agri-Food Canada (AAFC)
-
An Brian A Huynh,
Junior Policy Analyst
| Social Development Policy
|
Employment and Social Development Canada (ESDC)
-
Erin Krzyzanowski,
Manager
| Social Development Policy
|
Employment and Social Development Canada (ESDC)
-
Kaitlin Blackhall,
Manager
| Strategic Policy
|
Employment and Social Development Canada (ESDC)
-
Marebame Longe,
Manager
| Strategic Policy
|
Employment and Social Development Canada (ESDC)
-
Poppy Vineberg,
Director
| Strategic Horizontal Social Policy
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2023-02-10
Posted date:
2023-02-15
Communication number:
360616-556448
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Adam van Koeverden, ,
Parliamentary Secretary to the Minister of Health and to the Minister of Sport
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-12-13
Posted date:
2022-12-15
Communication number:
360616-551769
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Annie Comtois,
Acting Executive Director
| EXECUTIVE DIRECTOR OFFICE BUREAU DE LA DIRECTRICE EXÉCUTIVE EDO-BDE
|
Public Health Agency of Canada (PHAC)
-
David Luchuk,
Manager
| Centre for Chronic Disease Prevention and Health Equity
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2022-11-25
Posted date:
2022-12-15
Communication number:
360616-551750
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Tasha Stefanis,
Associate Vice President
| Health Promotion and Chronic Disease Prevention
|
Public Health Agency of Canada (PHAC)
-
Pamela Turpin,
Manager
|
Public Health Agency of Canada (PHAC)
-
Annie Comtois,
Director, Programs and Performance
| Centre for Chronic Disease Prevention and Health Equity
|
Public Health Agency of Canada (PHAC)
-
Mark Nafekh,
Director General, Centre for Chronic Disease Prevention and Health Equity
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2022-09-26
Posted date:
2022-12-15
Communication number:
360616-551859
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Nathanielle Morin,
Policy Advisor
| Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-08-30
Posted date:
2022-12-15
Communication number:
360616-551874
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Mark Nafekh,
Director General, Centre for Chronic Disease Prevention and Health Equity
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2022-07-21
Posted date:
2022-12-15
Communication number:
360616-551851
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Patrick Delorme,
Policy Analyst
| PHAC
|
Public Health Agency of Canada (PHAC)
-
Nolan D’Souza,
Program/Policy Fellow
| PHAC
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2022-04-25
Posted date:
2022-12-15
Communication number:
360616-551845
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Kathy Thompson,
Executive Vice-President of the Public Health Agency of Canada
| PHAC
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2022-04-05
Posted date:
2022-12-15
Communication number:
360616-551843
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Heather Jeffrey,
Associate Deputy Minister of Health
|
Health Canada (HC)
-
Adam Van Koeverden,
Member of Parliament
| Parliamentary Secretary to the Minister of Health and Sport
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-04-04
Posted date:
2022-12-15
Communication number:
360616-552263
(amended from
360616-551831)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Stephen Ellis,
Member of Parliament, Cumberland-Colchester
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-03-15
Posted date:
2022-12-15
Communication number:
360616-551788
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Michael Barrett,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-03-10
Posted date:
2022-03-10
Communication number:
360616-524796
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Lindsay Mathyssen,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-02-28
Posted date:
2022-03-09
Communication number:
360616-524604
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Carol Hughes,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-02-28
Posted date:
2022-03-09
Communication number:
360616-524599
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Nathanielle Morin,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-02-25
Posted date:
2022-03-09
Communication number:
360616-524594
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rebecca Caldwell,
Senior Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2022-02-22
Posted date:
2022-03-09
Communication number:
360616-523631
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Ziad Aboultaif,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-02-15
Posted date:
2022-03-09
Communication number:
360616-523595
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Chris d'Entremont,
Member of Pariament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-11-23
Posted date:
2021-12-15
Communication number:
360616-516121
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sonia Sidhu,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-11-05
Posted date:
2021-11-16
Communication number:
360616-516015
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Marie-France Lalonde,
Member of Parliament
| Orléans
|
House of Commons
Subject Matter of the communication:
Health,
Industry
Communication date:
2021-04-01
Posted date:
2021-05-15
Communication number:
360616-500466
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Marie-France Lalonde,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-03-22
Posted date:
2021-04-15
Communication number:
360616-500123
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Scott Aitchison,
Member of Parliament
| Parry Sound—Muskoka
|
House of Commons
Subject Matter of the communication:
Health,
Arts and Culture
Communication date:
2021-02-08
Posted date:
2021-03-15
Communication number:
360616-494594
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sonia Sidhu,
Member of Parliament
| Brampton South
|
House of Commons
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2021-01-18
Posted date:
2021-02-15
Communication number:
360616-493912
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Chris D'Entremont,
Member of Parliament
| West Nova
|
House of Commons
Subject Matter of the communication:
Health,
Research and Development,
Arts and Culture
Communication date:
2020-10-29
Posted date:
2020-11-16
Communication number:
360616-485814
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Helena Jaczek,
Member of Parliament
| Markham—Stouffville
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology,
Arts and Culture
Communication date:
2020-10-26
Posted date:
2020-11-16
Communication number:
360616-485816
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Ali Ehsassi,
Parliamentary Secretary
| Innovation and Industry
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Research and Development,
Arts and Culture
Communication date:
2020-10-20
Posted date:
2020-11-16
Communication number:
360616-485585
(amended from
360616-485584)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Judith Seidman,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health,
Research and Development,
Arts and Culture
Communication date:
2020-10-16
Posted date:
2020-11-16
Communication number:
360616-485815
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Amanda Woodley,
Special Assistant, Policy and Assistant to the Parliamentary Secretary
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Science and Technology,
Arts and Culture
Communication date:
2020-09-14
Posted date:
2020-10-15
Communication number:
360616-481823
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
William Amos,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology,
Industry,
Arts and Culture
Communication date:
2020-09-11
Posted date:
2020-10-15
Communication number:
360616-481820
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Christine Loth-Bown,
Vice-President
| Indigenous Affairs and Cultural Heritage Directorate
|
Parks Canada (PC)
Subject Matter of the communication:
Arts and Culture
Communication date:
2020-08-31
Posted date:
2021-07-14
Communication number:
360616-510412
(amended from
360616-481813)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sonia Sidhu,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Research and Development,
Arts and Culture
Communication date:
2020-07-17
Posted date:
2020-08-15
Communication number:
360616-478477
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Janet McPhee,
Senior Investment Officer
|
Global Affairs Canada (GAC)
-
Zoe Hawa,
Deputy Director, Life Sciences
|
Global Affairs Canada (GAC)
-
Louise Rousseau,
Deputy Director - Geographic (Europe)
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Science and Technology,
Industry,
Employment and Training
Communication date:
2019-02-26
Posted date:
2019-03-15
Communication number:
360616-447035
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Arthur Lam,
Senior Advisor
| Small Business Minister's Office and Export Promotion
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Industry,
Internal Trade,
Employment and Training
Communication date:
2019-02-26
Posted date:
2019-03-15
Communication number:
360616-447034
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Emily Yorke,
Senior Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Economic Development,
Health,
Industry,
Regional Development
Communication date:
2019-02-26
Posted date:
2019-03-15
Communication number:
360616-447030
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Industry
Communication date:
2019-02-20
Posted date:
2019-03-15
Communication number:
360616-447033
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Industry,
Employment and Training
Communication date:
2019-02-11
Posted date:
2019-03-15
Communication number:
360616-447032
(amended from
360616-447031)
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Science and Technology,
Industry
Communication date:
2019-01-30
Posted date:
2019-02-15
Communication number:
360616-444411
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Industry
Communication date:
2019-01-22
Posted date:
2019-02-15
Communication number:
360616-444410
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Manager
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
-
Edward Burrows,
Analyst / Economist
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
-
Tereasa Chudy,
Economist
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Industry
Communication date:
2019-01-09
Posted date:
2019-02-04
Communication number:
360616-444409
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Sr Project Leader
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
-
Jessica Godard,
Junior Analyst
| LSID
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Science and Technology,
Industry,
International Development,
International Trade
Communication date:
2018-12-14
Posted date:
2018-12-17
Communication number:
360616-442796
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Kevin Deagle,
Policy Advisor
|
Indigenous Services Canada (ISC)
-
Kathy Kettler,
Advisor
|
Indigenous Services Canada (ISC)
Subject Matter of the communication:
Economic Development,
Health,
International Relations,
Regional Development,
Aboriginal Affairs
Communication date:
2018-12-14
Posted date:
2018-12-17
Communication number:
360616-442795
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Regional Development,
Aboriginal Affairs
Communication date:
2018-12-13
Posted date:
2018-12-17
Communication number:
360616-442793
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Doug Clark,
Executive Director
|
Patented Medicine Prices Review Board (PMPRB)
-
Tanya Potashnick,
Director
|
Patented Medicine Prices Review Board (PMPRB)
-
Matthew Kellison,
Director
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Health,
Industry
Communication date:
2018-12-11
Posted date:
2018-12-17
Communication number:
360616-442783
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Kevin Deagle,
Policy Advisor
|
Indigenous Services Canada (ISC)
-
Joseph Wabegijig,
Policy Advisor
|
Indigenous Services Canada (ISC)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Industry,
Aboriginal Affairs
Communication date:
2018-11-16
Posted date:
2018-11-26
Communication number:
360616-440208
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Kate Proctor,
Policy Advisor
|
Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development,
Industry
Communication date:
2018-11-16
Posted date:
2018-11-26
Communication number:
360616-440207
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
rodrigo Arancibia,
Director
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Sr Project Leader
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development,
Science and Technology,
Industry
Communication date:
2018-11-16
Posted date:
2018-11-26
Communication number:
360616-440206
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Kate Moussouni,
Senior Policy Advisor
|
Health Canada (HC)
Subject Matter of the communication:
Economic Development,
Health,
Research and Development
Communication date:
2018-11-16
Posted date:
2018-11-26
Communication number:
360616-440205
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Deputy Minister
|
Health Canada (HC)
-
Abby Hoffman,
Assistant Deputy Minister
| Strategic Policy Branch (SPB)
|
Health Canada (HC)
-
Kathryn Nowers,
Director of Policy
| Office of the Minister
|
Health Canada (HC)
-
John Knubley,
Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Eric Dagenais,
Assistant Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Paul Halucha,
Assistant Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
David McFarlane,
Director of Policy
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Intellectual Property,
Science and Technology,
Industry,
Internal Trade
Communication date:
2018-10-05
Posted date:
2018-10-26
Communication number:
360616-436555
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Gabe Frost,
Senior Policy Analyst
| Regulatory Review
|
Treasury Board Of Canada Secretariat (TBS)
-
Rob Turk,
Policy Advisor
| Food and Agriculture Regulatory Reviews
|
Treasury Board Of Canada Secretariat (TBS)
-
Christopher Lee,
Research Analyst
| Regulatory Reviews
|
Treasury Board Of Canada Secretariat (TBS)
-
Alan Neeff,
Director
| Regulatory Policy Cooperation
|
Treasury Board Of Canada Secretariat (TBS)
-
Alexandra Nur,
Senior Policy Advisor
|
Treasury Board Of Canada Secretariat (TBS)
-
Barn-Yen Li,
Senior Advisor
|
Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-08-29
Posted date:
2018-09-07
Communication number:
360616-433231
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Policy Advisor
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development,
Science and Technology
Communication date:
2018-08-29
Posted date:
2018-09-07
Communication number:
360616-433230
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
John Oliver,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-08-27
Posted date:
2018-09-07
Communication number:
360616-433227
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Maximilien Roy,
Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development,
Science and Technology
Communication date:
2018-08-09
Posted date:
2018-09-07
Communication number:
360616-433229
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Senior Policy Analyst
|
Innovation, Science and Economic Development Canada (ISED)
-
Razan Shahin,
Sector Analyst
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-07-18
Posted date:
2018-09-07
Communication number:
360616-433228
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Mathieu Bouchard,
Senior Advisor
|
Prime Minister's Office (PMO)
-
Elder Marques,
Senior Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development,
Science and Technology
Communication date:
2018-07-12
Posted date:
2018-09-07
Communication number:
360616-433226
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Christopher Berzins,
Director of Policy
| Trade Minister's Office
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-07-12
Posted date:
2018-09-07
Communication number:
360616-433225
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Shawn Tupper,
Assistant Secretary to Cabinet, Economic and Regional Development Policy (Operations)
|
Privy Council Office (PCO)
-
Marian Campbell Jarvis,
Assistant Secretary to the Cabinet, Social Development Policy
|
Privy Council Office (PCO)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-07-12
Posted date:
2018-09-07
Communication number:
360616-433224
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
John Oliver,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property
Communication date:
2018-05-08
Posted date:
2018-09-07
Communication number:
360616-433223
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Janet MacPhee,
A/Director
|
Global Affairs Canada (GAC)
-
Kim Ryel,
Manager, life sciences
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-05-08
Posted date:
2018-09-07
Communication number:
360616-433222
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sheryl Groeneweg,
Director General
| Manufacturing and Life Sciences Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Nancy Nancy Faraday-Smith,
A/Director
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-05-08
Posted date:
2018-09-07
Communication number:
360616-433221
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Douglas Clark,
Executive Director
| PMPRB
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Economic Development,
Health,
Intellectual Property,
Research and Development
Communication date:
2018-05-08
Posted date:
2018-09-07
Communication number:
360616-433220
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Bill Morneau,
Minister of Finance
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2018-03-01
Posted date:
2018-04-16
Communication number:
360616-420970
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Ramez Ayoub,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2018-02-20
Posted date:
2018-03-15
Communication number:
360616-420969
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Sonia Sidhu,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2018-02-15
Posted date:
2018-03-15
Communication number:
360616-420968
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
David Clemens,
Manager, Business Development and Analytics
|
Canadian Institutes of Health Research (CIHR)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2017-12-05
Posted date:
2018-03-06
Communication number:
360616-420967
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Corinne Guenette,
Director, Life Science Industries, Manufacturing and Life Sciences Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Shawn Tippins,
Policy Analyst, Industry Sector – Life Sciences
|
Innovation, Science and Economic Development Canada (ISED)
-
Nancy Faraday-Smith,
Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development
|
Innovation, Science and Economic Development Canada (ISED)
-
Benoit Leduc,
Manager, Life Sciences Industries, Manufacturing and Life Sciences Branch, Innovation Science and Economic Development
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development
Communication date:
2017-12-05
Posted date:
2018-03-06
Communication number:
360616-420966
View associated registration
-
Novo Nordisk Canada Inc.
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Pam Goldsmith Jones,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2017-12-05
Posted date:
2018-03-06
Communication number:
360616-420965
View associated registration